298 related articles for article (PubMed ID: 31387947)
1. FRET-based analysis of the cardiac troponin T linker region reveals the structural basis of the hypertrophic cardiomyopathy-causing Δ160E mutation.
Abdullah S; Lynn ML; McConnell MT; Klass MM; Baldo AP; Schwartz SD; Tardiff JC
J Biol Chem; 2019 Oct; 294(40):14634-14647. PubMed ID: 31387947
[TBL] [Abstract][Full Text] [Related]
2. Allosteric effects of cardiac troponin TNT1 mutations on actomyosin binding: a novel pathogenic mechanism for hypertrophic cardiomyopathy.
Moore RK; Abdullah S; Tardiff JC
Arch Biochem Biophys; 2014 Jun; 552-553():21-8. PubMed ID: 24480310
[TBL] [Abstract][Full Text] [Related]
3. Molecular effects of familial hypertrophic cardiomyopathy-related mutations in the TNT1 domain of cTnT.
Manning EP; Tardiff JC; Schwartz SD
J Mol Biol; 2012 Aug; 421(1):54-66. PubMed ID: 22579624
[TBL] [Abstract][Full Text] [Related]
4. HCM-linked ∆160E cardiac troponin T mutation causes unique progressive structural and molecular ventricular remodeling in transgenic mice.
Moore RK; Grinspan LT; Jimenez J; Guinto PJ; Ertz-Berger B; Tardiff JC
J Mol Cell Cardiol; 2013 May; 58():188-98. PubMed ID: 23434821
[TBL] [Abstract][Full Text] [Related]
5. Clinically Divergent Mutation Effects on the Structure and Function of the Human Cardiac Tropomyosin Overlap.
McConnell M; Tal Grinspan L; Williams MR; Lynn ML; Schwartz BA; Fass OZ; Schwartz SD; Tardiff JC
Biochemistry; 2017 Jul; 56(26):3403-3413. PubMed ID: 28603979
[TBL] [Abstract][Full Text] [Related]
6. Structure and Dynamics of the Flexible Cardiac Troponin T Linker Domain in a Fully Reconstituted Thin Filament.
Deranek AE; Baldo AP; Lynn ML; Schwartz SD; Tardiff JC
Biochemistry; 2022 Jul; 61(13):1229-1242. PubMed ID: 35696530
[TBL] [Abstract][Full Text] [Related]
7. Basic residues within the cardiac troponin T C terminus are required for full inhibition of muscle contraction and limit activation by calcium.
Johnson D; Zhu L; Landim-Vieira M; Pinto JR; Chalovich JM
J Biol Chem; 2019 Dec; 294(51):19535-19545. PubMed ID: 31712308
[TBL] [Abstract][Full Text] [Related]
8. Cardiac troponin T N-domain variant destabilizes the actin interface resulting in disturbed myofilament function.
Landim-Vieira M; Ma W; Song T; Rastegarpouyani H; Gong H; Coscarella IL; Bogaards SJP; Conijn SP; Ottenheijm CAC; Hwang HS; Papadaki M; Knollmann BC; Sadayappan S; Irving TC; Galkin VE; Chase PB; Pinto JR
Proc Natl Acad Sci U S A; 2023 Jun; 120(23):e2221244120. PubMed ID: 37252999
[TBL] [Abstract][Full Text] [Related]
9. Cardiac troponin T mutation R141W found in dilated cardiomyopathy stabilizes the troponin T-tropomyosin interaction and causes a Ca2+ desensitization.
Lu QW; Morimoto S; Harada K; Du CK; Takahashi-Yanaga F; Miwa Y; Sasaguri T; Ohtsuki I
J Mol Cell Cardiol; 2003 Dec; 35(12):1421-7. PubMed ID: 14654368
[TBL] [Abstract][Full Text] [Related]
10. Perturbed length-dependent activation in human hypertrophic cardiomyopathy with missense sarcomeric gene mutations.
Sequeira V; Wijnker PJ; Nijenkamp LL; Kuster DW; Najafi A; Witjas-Paalberends ER; Regan JA; Boontje N; Ten Cate FJ; Germans T; Carrier L; Sadayappan S; van Slegtenhorst MA; Zaremba R; Foster DB; Murphy AM; Poggesi C; Dos Remedios C; Stienen GJ; Ho CY; Michels M; van der Velden J
Circ Res; 2013 May; 112(11):1491-505. PubMed ID: 23508784
[TBL] [Abstract][Full Text] [Related]
11. Effects of troponin T cardiomyopathy mutations on the calcium sensitivity of the regulated thin filament and the actomyosin cross-bridge kinetics of human β-cardiac myosin.
Sommese RF; Nag S; Sutton S; Miller SM; Spudich JA; Ruppel KM
PLoS One; 2013; 8(12):e83403. PubMed ID: 24367593
[TBL] [Abstract][Full Text] [Related]
12. Dilated and hypertrophic cardiomyopathy mutations in troponin and alpha-tropomyosin have opposing effects on the calcium affinity of cardiac thin filaments.
Robinson P; Griffiths PJ; Watkins H; Redwood CS
Circ Res; 2007 Dec; 101(12):1266-73. PubMed ID: 17932326
[TBL] [Abstract][Full Text] [Related]
13. Ca(2+)-regulatory function of the inhibitory peptide region of cardiac troponin I is aided by the C-terminus of cardiac troponin T: Effects of familial hypertrophic cardiomyopathy mutations cTnI R145G and cTnT R278C, alone and in combination, on filament sliding.
Brunet NM; Chase PB; Mihajlović G; Schoffstall B
Arch Biochem Biophys; 2014 Jun; 552-553():11-20. PubMed ID: 24418317
[TBL] [Abstract][Full Text] [Related]
14. M8R tropomyosin mutation disrupts actin binding and filament regulation: The beginning affects the middle and end.
Racca AW; Rynkiewicz MJ; LaFave N; Ghosh A; Lehman W; Moore JR
J Biol Chem; 2020 Dec; 295(50):17128-17137. PubMed ID: 33020181
[TBL] [Abstract][Full Text] [Related]
15. Novel insights on the relationship between T-tubular defects and contractile dysfunction in a mouse model of hypertrophic cardiomyopathy.
Crocini C; Ferrantini C; Scardigli M; Coppini R; Mazzoni L; Lazzeri E; Pioner JM; Scellini B; Guo A; Song LS; Yan P; Loew LM; Tardiff J; Tesi C; Vanzi F; Cerbai E; Pavone FS; Sacconi L; Poggesi C
J Mol Cell Cardiol; 2016 Feb; 91():42-51. PubMed ID: 26714042
[TBL] [Abstract][Full Text] [Related]
16. Investigation of a truncated cardiac troponin T that causes familial hypertrophic cardiomyopathy: Ca(2+) regulatory properties of reconstituted thin filaments depend on the ratio of mutant to wild-type protein.
Redwood C; Lohmann K; Bing W; Esposito GM; Elliott K; Abdulrazzak H; Knott A; Purcell I; Marston S; Watkins H
Circ Res; 2000 Jun; 86(11):1146-52. PubMed ID: 10850966
[TBL] [Abstract][Full Text] [Related]
17. Molecular mechanisms regulating the myofilament response to Ca2+: implications of mutations causal for familial hypertrophic cardiomyopathy.
Palmiter KA; Solaro RJ
Basic Res Cardiol; 1997; 92 Suppl 1():63-74. PubMed ID: 9202846
[TBL] [Abstract][Full Text] [Related]
18. Dilated cardiomyopathy mutations in three thin filament regulatory proteins result in a common functional phenotype.
Mirza M; Marston S; Willott R; Ashley C; Mogensen J; McKenna W; Robinson P; Redwood C; Watkins H
J Biol Chem; 2005 Aug; 280(31):28498-506. PubMed ID: 15923195
[TBL] [Abstract][Full Text] [Related]
19. Human-Induced Pluripotent Stem Cell-Derived Cardiomyocyte Model for
Kondo T; Higo S; Shiba M; Kohama Y; Kameda S; Tabata T; Inoue H; Okuno S; Ogawa S; Nakamura S; Takeda M; Ito E; Li J; Liu L; Kuramoto Y; Lee JK; Takashima S; Miyagawa S; Sawa Y; Hikoso S; Sakata Y
Circ Genom Precis Med; 2022 Oct; 15(5):e003522. PubMed ID: 35861968
[TBL] [Abstract][Full Text] [Related]
20.
Madan A; Viswanathan MC; Woulfe KC; Schmidt W; Sidor A; Liu T; Nguyen TH; Trinh B; Wilson C; Madathil S; Vogler G; O'Rourke B; Biesiadecki BJ; Tobacman LS; Cammarato A
Proc Natl Acad Sci U S A; 2020 Aug; 117(31):18822-18831. PubMed ID: 32690703
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
